Epigenetics in human disease and prospects for epigenetic therapy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'--several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [39]
In the citing paper
“and represents a prominent candidate to be a marker of ROS-induced mutagenesis and tumorigenesis41.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [41]
In the citing paper
“Activation and/or aberrant expression of a gene can contribute to the development of endometriosis, cancers, or other abnormalities.22”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [22]
In the citing paper
“Many reports have demonstrated that epigenetic alterations play important roles in driving cancer initiation and progression [123, 124].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [123]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“On a more global level, the ICF (immunodeficiency, centromeric region instability and facial anomalies) syndrome is caused by mutations in the DNMT3b gene, which is an essential enzyme required for the establishment of DNA methylation pattern”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Cited by
Items 201–300 of 1,013
Reinert, T., Modin, C., Castano, F. M., Lamy, P., Wojdacz, T. K., Hansen, L. L., Wiuf, C., Borre, M., Dyrskjøt, L., & Ørntoft, T. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2659 · Cited by 207
Jover, R., Nguyen, T., Pérez–Carbonell, L., Zapater, P., Payá, A., Alenda, C., Rojas, E., Cubiella, J., Balaguer, F., Morillas, J. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.035 · Cited by 205
Dynamics and Context-Dependent Roles of DNA Methylation
Ambrosi, C., Manzo, M., & Baubec, T. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.02.008 · Cited by 186
Dysregulation of p53/Sp1 Control Leads to DNA Methyltransferase-1 Overexpression in Lung Cancer
Lin, R.-K., Wu, C.-Y., Chang, J.-W., Juan, L.-J., Hsu, H.-S., Chen, C.-Y., Lu, Y.-Y., Tang, Y.-A., Yang, Y.-C., Yang, P.-C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4161 · Cited by 200
Paluszczak, J., Krajka-Kuźniak, V., & Baer-Dubowska, W. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2009.10.010 · Cited by 199
Epigenetic mechanisms in diabetic vascular complications
Reddy, M. A., & Natarajan, R. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr024 · Cited by 199
“Reversal of epigenetic mechanisms or ‘epigenetic therapy’ can be effective in pathological conditions as shown in the treatment of certain cancers.(103) An anti-inflammatory agent and HAT inhibitor curcumin ameliorated HG-induced inflammatory gene expression and histone acetylation at their promoters as well as change…”
BackgroundDNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment
Barton, C. A., Hacker, N. F., Clark, S. J., & O'Brien, P. M. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.12.017 · Cited by 200
Selective Anchoring of DNA Methyltransferases 3A and 3B to Nucleosomes Containing Methylated DNA
Jeong, S., Liang, G., Sharma, S., Lin, J. C., Choi, S. H., Han, H., Yoo, C. B., Egger, G., Yang, A. S., & Jones, P. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00484-09 · Cited by 192
Self-citationInhibition of endogenous reverse transcriptase antagonizes human tumor growth
Sciamanna, I., Landriscina, M., Pittoggi, C., Quirino, M., Mearelli, C., Beraldi, R., Mattei, E., Serafino, A., Cassano, A., Sinibaldi-Vallebona, P., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208562 · Cited by 198
“Therefore, epigenetic regulatory factors are viewed as valuable, worth-challenging targets in tumor therapy (Egger et al., 2004).”
BackgroundThe epigenetics of autoimmunity
Meda, F., Folci, M., Baccarelli, A., & Selmi, C. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.78 · Cited by 193
Epigenetics and Oxidative Stress in Aging
Guillaumet-Adkins, A., Yañez, Y., Peris-Diaz, M. D., Calabria, I., Palanca-Ballester, C., & Sandoval, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9175806 · Cited by 193
Role of nuclear glutathione as a key regulator of cell proliferation
Pallardó, F. V., Markovic, J., García, J. L., & Viña, J. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.01.001 · Cited by 191
Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms
Li, Y., Liu, L., Andrews, L. G., & Tollefsbol, T. O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24398 · Cited by 194
Epigenetic regulation of caloric restriction in aging
Li, Y., Daniel, M., & Tollefsbol, T. O. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-98 · Cited by 189
Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
Lin, J., Haffner, M. C., Zhang, Y., Lee, B. H., Brennen, W. N., Britton, J., Kachhap, S. K., Shim, J. S., Liu, J. O., Nelson, W. G., et al. (2011) · The Prostate · doi:10.1002/pros.21247 · Cited by 194
“One major disadvantage of 5-azaC and 5-aza-dC is that they are nucleoside analogs, whose mechanism of action involves incorporation of the aza-modified base into DNA during DNA synthesis with subsequent covalent trapping of the DNMT [17,18].”
BackgroundUnderstanding and Determining the Etiology of Autism
Currenti, S. A. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9453-8 · Cited by 182
Hong, J. A., Kang, Y., Abdullaev, Z., Flanagan, P. T., Pack, S. D., Fischette, M. R., Adnani, M. T., Loukinov, D. I., Vatolin, S., Risinger, J. I., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0823 · Cited by 197
FTO and Obesity: Mechanisms of Association
Zhao, X., Yang, Y., Sun, B.-F., Zhao, Y.-L., & Yang, Y.-G. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0486-0 · Cited by 189
Shi, Y., Sun, G., Zhao, C., & Stewart, R. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.06.004 · Cited by 188
Zebularine: a new drug for epigenetic therapy
Yoo, C. B., Cheng, J. C., & Jones, P. A. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320910 · Cited by 191
Self-citationHow epigenetics impacts on human diseases
Farsetti, A., Illi, B., & Gaetano, C. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.05.036 · Cited by 161
Palmieri, G., Capone, M., Ascierto, M. L., Gentilcore, G., Stroncek, D. F., Casula, M., Sini, M. C., Palla, M., Mozzillo, N., & Ascierto, P. A. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-86 · Cited by 177
Nilsson, E. E., Anway, M. D., Stanfield, J., & Skinner, M. K. (2008) · REPRODUCTION · doi:10.1530/rep-07-0542 · Cited by 184
Kuratomi, G., Iwamoto, K., Bundo, M., Kusumi, I., Kato, N., Iwata, N., Ozaki, N., & Kato, T. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002001 · Cited by 188
Fuentes, F., Paredes-Gonzalez, X., & Kong, A.-N. T. (2015) · Current Pharmacology Reports · doi:10.1007/s40495-015-0017-y · Cited by 184
Pflueger, C., Tan, D., Swain, T., Nguyen, T., Pflueger, J., Nefzger, C., Polo, J. M., Ford, E., & Lister, R. (2018) · Genome Research · doi:10.1101/gr.233049.117 · Cited by 188
“…in development, pathogenesis of various disease states, and is frequently associated with transcriptional repression (Okano et al. 1999; Jackson-Grusby et al. 2001; Egger et al. 2004; Smith & Meissner 2013; Bernstein et al. 2007; Perino & Veenstra 2016; Li et al. 1992; Gao & Teschendorff 2017).”
BackgroundMicroRNAs miR-30b, miR-30d, and miR-494 Regulate Human Endometrial Receptivity
Altmäe, S., Martinez-Conejero, J. A., Esteban, F. J., Ruiz-Alonso, M., Stavreus-Evers, A., Horcajadas, J. A., & Salumets, A. (2013) · Reproductive Sciences · doi:10.1177/1933719112453507 · Cited by 190
Ramanan, V. K., & Saykin, A. J. (2013) · Europe PMC (PubMed Central) · Cited by 259
Ushmorov, A., Leithäuser, F., Sakk, O., Weinhaüsel, A., Popov, S. W., Möller, P., & Wirth, T. (2006) · Blood · doi:10.1182/blood-2005-09-3765 · Cited by 179
Shen, L., Catalano, P. J., Benson, A. B., O'Dwyer, P., Hamilton, S. R., & Issa, J.-P. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1011 · Cited by 184
Aberrant methylations in cancer cells: Where do they come from?
Ushijima, T., & Okochi‐Takada, E. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00035.x · Cited by 185
Murrell, A., Rakyan, V. K., & Beck, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi110 · Cited by 184
“Epigenetic therapies propose using global DNA methylation inhibitors to reverse gene silencing caused by altered methylation (67).”
BackgroundHeterochromatic Genome Stability Requires Regulators of Histone H3 K9 Methylation
Peng, J. C., & Karpen, G. H. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000435 · Cited by 183
“Current epigenomic characterizations of different cancer types also put great emphasis on epigenetic regulation of transcription, showing dramatic chromatin alterations of oncogenes or tumor suppressor genes whose transcriptional deregulation contribute to cancer progression [55,56].”
BackgroundWolff, E. M., Chihara, Y., Pan, F., Weisenberger, D. J., Siegmund, K. D., Sugano, K., Kawashima, K., Laird, P. W., Jones, P. A., & Liang, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1335 · Cited by 180
Self-citationColorectal cancer: a model for epigenetic tumorigenesis
Wong, J. J. L., Hawkins, N. J., & Ward, R. L. (2007) · Gut · doi:10.1136/gut.2005.088799 · Cited by 178
Castellano, S., Kuck, D., Viviano, M., Yoo, J., López-Vallejo, F., Conti, P., Tamborini, L., Pinto, A., Medina-Franco, J. L., & Sbardella, G. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2010404 · Cited by 179
DNA methylation enables transposable element-driven genome expansion
Zhou, W., Liang, G., Molloy, P. L., & Jones, P. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921719117 · Cited by 181
“We know that Alus can act as “ methylation centers ” after insertion into host DNA, whereby methylation subsequently spreads into the flanking DNA (13 – 15).”
Self-citationZama, A. M., & Uzumcu, M. (2009) · Endocrinology · doi:10.1210/en.2009-0499 · Cited by 174
Insulin Resistance and Cancer: In Search for a Causal Link
Chiefari, E., Mirabelli, M., La Vignera, S., Tanyolaç, S., Foti, D. P., Aversa, A., & Brunetti, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011137 · Cited by 170
Gius, D., Cui, H., Bradbury, C. M., Cook, J., Smart, D. K., Zhao, S., Young, L., Brandenburg, S. A., Hu, Y., Bisht, K. S., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.029 · Cited by 181
Epigenetic drivers and genetic passengers on the road to cancer
Sawan, C., Vaissière, T., Murr, R., & Herceg, Z. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.03.002 · Cited by 166
Curcumin as a regulator of epigenetic events
Teiten, M., Dicato, M., & Diederich, M. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300201 · Cited by 172
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation
Rialdi, A., Campisi, L., Zhao, N., Lagda, A. C., Pietzsch, C., Ho, J. S. Y., Martinez-Gil, L., Fenouil, R., Chen, X., Edwards, M., et al. (2016) · Science · doi:10.1126/science.aad7993 · Cited by 178
Epigenetic regulation and fetal programming
Gicquel, C., El-Osta, A., & Le Bouc, Y. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.07.009 · Cited by 169
Kuck, D., Singh, N., Lyko, F., & Medina-Franco, J. L. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.11.050 · Cited by 176
Uddin, M., Koenen, K. C., Aiello, A. E., Wildman, D. E., de los Santos, R., & Galea, S. (2011) · Psychological Medicine · doi:10.1017/s0033291710001674 · Cited by 174
MicroRNA-mediated drug resistance in breast cancer
Kutanzi, K. R., Yurchenko, O. V., Beland, F. A., Checkhun, V. F., & Pogribny, I. P. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0040-8 · Cited by 170
The many faces of histone H3K79 methylation
Farooq, Z., Banday, S., Pandita, T. K., & Altaf, M. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.03.005 · Cited by 163
Porcu, M., & Chiarugi, A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.009 · Cited by 173
Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders
Grayson, D. R., Kundakovic, M., & Sharma, R. P. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061333 · Cited by 171
Epigenetic mechanisms in the context of complex diseases
van Vliet, J., Oates, N. A., & Whitelaw, E. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6526-z · Cited by 173
The ecology and evolutionary endocrinology of reproduction in the human female
Vitzthum, V. J. (2009) · American Journal of Physical Anthropology · doi:10.1002/ajpa.21195 · Cited by 165
Transgenerational epigenetic programming of the embryonic testis transcriptome
Anway, M. D., Rekow, S. S., & Skinner, M. K. (2008) · Genomics · doi:10.1016/j.ygeno.2007.10.002 · Cited by 165
Epigenomics: Technologies and Applications
Wang, K. C., & Chang, H. Y. (2018) · Circulation Research · doi:10.1161/circresaha.118.310998 · Cited by 169
“chromatin remodeling, histone modification, and noncoding RNA–associated mechanisms.(2) Earlier studies showed that heterochromatin and euchromatin are associated with distinct”
Rogers, N. L., Cole, S. A., Lan, H., Crossa, A., & Demerath, E. W. (2007) · American Journal of Human Biology · doi:10.1002/ajhb.20586 · Cited by 171
In Response to Abiotic Stress, DNA Methylation Confers EpiGenetic Changes in Plants
Akhter, Z., Bi, Z., Ali, K., Sun, C., Fiaz, S., Haider, F. U., & Bai, J. (2021) · Plants · doi:10.3390/plants10061096 · Cited by 192
Obesity-related hypertension: possible pathophysiological mechanisms
Vaněčková, I., Maletínská, L., Behuliak, M., Nagelová, V., Zicha, J., & Kuneš, J. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0368 · Cited by 161
Epigenetic aberrations and cancer.
Ducasse, M., & Brown, M. A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-60 · Cited by 200
Epigenetics: A way to bridge the gap between biological fields
Nicoglou, A., & Merlin, F. (2017) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2017.10.002 · Cited by 177
Histone deacetylases 1 and 2 are expressed at distinct stages of neuro‐glial development
MacDonald, J. L., & Roskams, A. J. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21626 · Cited by 166
The role of zinc in genomic stability
Sharif, R., Thomas, P., Zalewski, P., & Fenech, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.08.009 · Cited by 162
Kundakovic, M., Chen, Y., Costa, E., & Grayson, D. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.030635 · Cited by 167
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
Salvatore, T., Pafundi, P. C., Galiero, R., Albanese, G., Di Martino, A., Caturano, A., Vetrano, E., Rinaldi, L., & Sasso, F. C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.695792 · Cited by 165
“Epigenetics Epigenetics, the inheritable changes in gene expression without change of DNA sequences, represents a significant link between environmental exposure, as hyperglycemia, inflammation, and oxidative stress, and alterations in gene activity (210).”
BackgroundMetabolomic Fingerprinting: Challenges and Opportunities
Kosmides, A. K., Kamisoglu, K., Calvano, S. E., Corbett, S. A., & Androulakis, I. P. (2013) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2013007736 · Cited by 159
Hanley, B., Dijane, J., Fewtrell, M. S., Grynberg, A., Hummel, S., Junien, C., Koletzko, B. V., Lewis, S. J., Renz, H. E., Symonds, M. E., et al. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003338 · Cited by 184
Epigenome Mapping in Normal and Disease States
Maunakea, A. K., Chepelev, I., & Zhao, K. (2010) · Circulation Research · doi:10.1161/circresaha.110.222463 · Cited by 166
Issa, J. J., Kantarjian, H. M., & Kirkpatrick, P. N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1698 · Cited by 163
Zhang, Y., Rohde, C., Tierling, S., Jurkowski, T. P., Bock, C., Santacruz, D., Ragozin, S., Reinhardt, R., Groth, M., Walter, J., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000438 · Cited by 162
“Erroneous DNA methylation contributes to the development of human cancer and multifactorial diseases [10–12].”
Heat stress responses in spermatozoa: Mechanisms and consequences for cattle fertility
Rahman, M. B., Schellander, K., Luceño, N. L., & Soom, A. V. (2018) · Theriogenology · doi:10.1016/j.theriogenology.2018.02.012 · Cited by 180
Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation
Barwick, B. G., Scharer, C. D., Bally, A. P. R., & Boss, J. M. (2016) · Nature Immunology · doi:10.1038/ni.3519 · Cited by 152
Watanabe, H., Soejima, K., Yasuda, H., Kawada, I., Nakachi, I., Yoda, S., Naoki, K., & Ishizaka, A. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-15 · Cited by 154
BPA-Induced Deregulation Of Epigenetic Patterns: Effects On Female Zebrafish Reproduction
Santangeli, S., Maradonna, F., Gioacchini, G., Cobellis, G., Piccinetti, C. C., Valle, L. D., & Carnevali, O. (2016) · Scientific Reports · doi:10.1038/srep21982 · Cited by 167
Clinical and biological effects of demethylating agents on solid tumours – A systematic review
Linnekamp, J. F., Butter, R., Spijker, R., Medema, J. P., & van Laarhoven, H. W. M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.01.004 · Cited by 160
DNA methyltransferase inhibitors: old and new drugs for an epigenetic cancer therapy
Brueckner, B., & Lyko, F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.09.004 · Cited by 159
Fenech, M. (2005) · Mutagenesis · doi:10.1093/mutage/gei040 · Cited by 158
Epigenetics and airways disease
Adcock, I. M., Ford, P., Ito, K., & Barnes, P. J. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-21 · Cited by 152
Gamazon, E. R., Badner, J. A., Cheng, L., Zhang, C., Zhang, D., Cox, N. J., Gershon, E. S., Kelsoe, J. R., Greenwood, T. A., Nievergelt, C. M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.174 · Cited by 155
MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells
Yang, X.-J., & Ullah, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210609 · Cited by 175
Sharma, D., Blum, J., Yang, X., Beaulieu, N., Macleod, A. R., & Davidson, N. E. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0011 · Cited by 155
Epigenetic cancer therapy: rationales, targets and drugs
Rius, M., & Lyko, F. (2012) · Oncogene · doi:10.1038/onc.2011.601 · Cited by 157
Epigenetic Mechanisms Link Maternal Diets and Gut Microbiome to Obesity in the Offspring
Li, Y. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00342 · Cited by 149
Fandy, T. E., Shankar, S., Ross, D. D., Sausville, E., & Srivastava, R. K. (2005) · Neoplasia · doi:10.1593/neo.04655 · Cited by 154
DNA Methylation: a form of epigenetic control of gene expression
Lim, D. H. K., & Maher, E. R. (2010) · The Obstetrician & Gynaecologist · doi:10.1576/toag.12.1.037.27556 · Cited by 155
Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs
Roberts, T. C., Morris, K. V., & Weinberg, M. S. (2014) · Epigenetics · doi:10.4161/epi.26700 · Cited by 152
Active Listening for Spatial Orientation in a Complex Auditory Scene
Moss, C. F., Bohn, K., Gilkenson, H., & Surlykke, A. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040079 · Cited by 154
Genetic aspects of autism spectrum disorders: insights from animal models
Banerjee, S., Riordan, M., & Bhat, M. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00058 · Cited by 139
Sato, N., Fukushima, N., Chang, R., Matsubayashi, H., & Goggins, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.008 · Cited by 162
Prognostic DNA Methylation Biomarkers in Ovarian Cancer
Wei, S. H., Balch, C., Paik, H. H., Kim, Y.-S., Baldwin, R. L., Liyanarachchi, S., Li, L., Wang, Z., Wan, J. C., Davuluri, R. V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1551 · Cited by 154
Stem cells, senescence, neosis and self-renewal in cancer.
Rajaraman, R., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, S. R. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-25 · Cited by 169
Li, F., Papworth, M. A., Minczuk, M. A., Rohde, C., Zhang, Y., Ragozin, S., & Jeltsch, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1035 · Cited by 159
The interaction of genetic and environmental factors in the etiology of hypertension
Kuneš, J., & Zicha, J. (2009) · Physiological Research · doi:10.33549/physiolres.931913 · Cited by 170
Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers
Shigeyasu, K., Toden, S., Zumwalt, T. J., Okugawa, Y., & Goel, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1676 · Cited by 158
Skvortsova, T. E., RYKOVA, E. Y., TAMKOVICH, S. N., Bryzgunova, O. E., Starikov, A. V., Kuznetsova, N. P., Vlassov, V. V., & Laktionov, P. P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603117 · Cited by 155
Epigenetics in spermatogenesis
Trasler, J. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.018 · Cited by 150
Earlier Mother's Age at Menarche Predicts Rapid Infancy Growth and Childhood Obesity
Ong, K. K., Northstone, K., Wells, J. C., Rubin, C., Ness, A. R., Golding, J., & Dunger, D. B. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040132 · Cited by 151
Diagnostic and Therapeutic Applications of Epigenetics
Miyamoto, K., & Ushijima, T. (2005) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi088 · Cited by 163
De Felice, L., Tatarelli, C., Mascolo, M. G., Gregorj, C., Agostini, F., Fiorini, R., Gelmetti, V., Pascale, S., Padula, F., Petrucci, M. T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3063 · Cited by 149
Targeting DNA Methylation with Small Molecules: What’s Next?
Erdmann, A., Halby, L., Fahy, J., & Arimondo, P. B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500843d · Cited by 163
How epigenetics can explain human metastasis: A new role for microRNAs
Lujambio, A., & Esteller, M. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7526 · Cited by 144
Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
Yi, J. M., Tsai, H.-C., Glöckner, S. C., Lin, S. H., Ohm, J. E., Easwaran, H., James, C. D., Costello, J., Riggins, G. J., Eberhart, C. G., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6208 · Cited by 162
Metadata
- Authors
- Egger, G., Liang, G., Aparicio, A., & Jones, P. A.
- Affiliations
- University of Southern California (US)
- Venue
- Nature
- Published
- 2004-05
- Volume
- 429
- Issue
- 6990
- Pages
- 457-463
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004172747
- Cited by
- 3,232
- References
- 96
- Citations by year
- 2026: 32 · 2025: 76 · 2024: 100 · 2023: 132 · 2022: 124 · 2021: 175 · 2020: 140 · 2019: 173 · 2018: 185 · 2017: 192 · 2016: 180 · 2015: 208 · 2014: 159 · 2013: 175 · 2012: 153
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Max Kade Foundation
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- epigenetics, epigenetic therapy, DNA methylation, histone modifications, gene silencing, hypomethylating agents, histone deacetylase inhibitors, cancer, chromosomal instability syndromes, intellectual disability
- MeSH terms
- Disease, Genetics, Medical, Humans, Genetic Therapy, DNA Methylation, Gene Silencing, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.